Carbopol 980 NF 0.2% Based Medical Device
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Carbopol 980 NF 0.2% Based Medical Device, covering 2026-02-25 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy [NA]